• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪肝疾病对非肥胖、非糖尿病韩国男性 2 型糖尿病发展的影响。

Effect of nonalcoholic Fatty liver disease on the development of type 2 diabetes in nonobese, nondiabetic korean men.

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Gut Liver. 2012 Jul;6(3):368-73. doi: 10.5009/gnl.2012.6.3.368. Epub 2012 Jul 12.

DOI:10.5009/gnl.2012.6.3.368
PMID:22844567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3404176/
Abstract

BACKGROUND/AIMS: We have a limited understanding of the effect of nonalcoholic fatty liver disease (NAFLD) on the development of type 2 diabetes.

METHODS

The study subjects included male who had received biennial medical check-ups between 2005 and 2009 and who had been diagnosed with fatty liver disease. The subjects with sustained NAFLD (FL, n=107) and sustained non-NAFLD (NFL, n=1,054) were followed to determine the development of type 2 diabetes.

RESULTS

In the FL group, there were more subjects with impaired fasting glucose (IFG), type 2 diabetes and high HOMA-IR than there were in the NFL group during the 5-year follow-up period (32.7 vs. 17.6%, 1.9 vs. 0.3%, 17.9 vs. 5.2% respectively, p<0.05). The FL group showed a higher risk than NFL group for abnormal glucose metabolism as determined using IFG (odds ratio [OR], 2.13; confidence interval [CI], 1.36 to 3.35), type 2 diabetes (OR, 7.63; 95% CI, 1.03 to 56.79) and high HOMA-IR (OR, 3.25; 95% CI, 1.79 to 5.91) and metabolic parameters such as body mass index (OR, 3.35; 95% CI, 1.87 to 6.02), triglyceride (OR, 3.05; 95% CI, 1.92 to 4.86) and fasting blood sugar (OR, 2.18; 95% CI, 1.39 to 3.41).

CONCLUSIONS

Sustained NAFLD appears to be associated with an increased risk for the development of type 2 diabetes and deterioration of metabolic parameters in non-obese, non-diabetic Korean men.

摘要

背景/目的:我们对非酒精性脂肪性肝病(NAFLD)对 2 型糖尿病发展的影响知之甚少。

方法

研究对象包括 2005 年至 2009 年间接受两年一次体检且被诊断为脂肪肝的男性。对持续存在非酒精性脂肪肝(FL,n=107)和持续不存在非酒精性脂肪肝(NFL,n=1054)的患者进行随访,以确定 2 型糖尿病的发生情况。

结果

在 5 年的随访期间,FL 组空腹血糖受损(IFG)、2 型糖尿病和高胰岛素抵抗(HOMA-IR)的患者比例高于 NFL 组(分别为 32.7%比 17.6%、1.9%比 0.3%、17.9%比 5.2%,p<0.05)。FL 组发生异常葡萄糖代谢(IFG:比值比[OR],2.13;95%置信区间[CI],1.36 至 3.35)、2 型糖尿病(OR,7.63;95%CI,1.03 至 56.79)和高 HOMA-IR(OR,3.25;95%CI,1.79 至 5.91)的风险高于 NFL 组,代谢参数如体重指数(OR,3.35;95%CI,1.87 至 6.02)、甘油三酯(OR,3.05;95%CI,1.92 至 4.86)和空腹血糖(OR,2.18;95%CI,1.39 至 3.41)也更高。

结论

在非肥胖、非糖尿病的韩国男性中,持续存在的 NAFLD 似乎与 2 型糖尿病的发生风险增加和代谢参数恶化有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46ea/3404176/2e9e3ab32e48/gnl-6-368-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46ea/3404176/10c579d86dae/gnl-6-368-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46ea/3404176/2e9e3ab32e48/gnl-6-368-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46ea/3404176/10c579d86dae/gnl-6-368-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46ea/3404176/2e9e3ab32e48/gnl-6-368-g002.jpg

相似文献

1
Effect of nonalcoholic Fatty liver disease on the development of type 2 diabetes in nonobese, nondiabetic korean men.非酒精性脂肪肝疾病对非肥胖、非糖尿病韩国男性 2 型糖尿病发展的影响。
Gut Liver. 2012 Jul;6(3):368-73. doi: 10.5009/gnl.2012.6.3.368. Epub 2012 Jul 12.
2
Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease.年轻男性非酒精性脂肪性肝病患者的糖耐量异常。
Liver Int. 2009 Apr;29(4):525-9. doi: 10.1111/j.1478-3231.2008.01920.x.
3
IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.2 型糖尿病对非酒精性脂肪性肝病患者非酒精性脂肪性肝炎和肝纤维化进展的影响。
Endocr Pract. 2020 Apr;26(4):444-453. doi: 10.4158/EP-2019-0342. Epub 2020 Jan 22.
4
Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.台湾成年人群中非酒精性脂肪性肝病的患病率及危险因素:非肥胖成年人中非酒精性脂肪性肝病的代谢意义
J Clin Gastroenterol. 2006 Sep;40(8):745-52. doi: 10.1097/00004836-200609000-00016.
5
Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.非肥胖、非糖尿病成年人非酒精性脂肪性肝病的代谢意义
Arch Intern Med. 2004 Oct 25;164(19):2169-75. doi: 10.1001/archinte.164.19.2169.
6
Triglyceride level and soft drink consumption predict nonalcoholic fatty liver disease in nonobese male adolescents.甘油三酯水平和软饮料摄入量可预测非肥胖男性青少年的非酒精性脂肪性肝病。
Hepatol Res. 2023 Jun;53(6):497-510. doi: 10.1111/hepr.13889. Epub 2023 Mar 3.
7
Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.非酒精性脂肪性肝病对代谢紊乱发生发展的影响。
J Gastroenterol Hepatol. 2007 Jul;22(7):1086-91. doi: 10.1111/j.1440-1746.2006.04781.x.
8
Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses.胎球蛋白-B 通过诱导胰岛素抵抗将非酒精性脂肪性肝病与 2 型糖尿病联系起来:关联和路径分析。
Cytokine. 2018 Aug;108:145-150. doi: 10.1016/j.cyto.2018.03.023. Epub 2018 Mar 30.
9
Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus.2型糖尿病患者血糖、血清趋化素与胰岛素抵抗和非酒精性脂肪性肝病的相关性
Exp Ther Med. 2018 Mar;15(3):2936-2940. doi: 10.3892/etm.2018.5753. Epub 2018 Jan 16.
10
Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study.在血脂水平正常的非肥胖中国人群中,空腹血糖与非酒精性脂肪肝之间的关系:一项前瞻性队列研究。
Lipids Health Dis. 2020 Jun 20;19(1):145. doi: 10.1186/s12944-020-01326-3.

引用本文的文献

1
Glucagon, Metabolic Dysfunction-Associated Steatotic Liver Disease and Amino Acids in Humans and Animals without Diabetes Mellitus-An Evidence Map.胰高血糖素、代谢功能障碍相关脂肪性肝病与非糖尿病人类和动物体内的氨基酸——一项证据图谱
Life (Basel). 2024 Oct 12;14(10):1292. doi: 10.3390/life14101292.
2
Genetic and Lifestyle Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Relationship with Premature Coronary Artery Disease: A Study on the Pars Cohort.遗传和生活方式因素与代谢相关脂肪性肝病及其与早发冠心病的关系:帕斯卡队列研究。
Arch Iran Med. 2024 May 1;27(5):248-254. doi: 10.34172/aim.2024.36.
3

本文引用的文献

1
Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects.非酒精性脂肪性肝病对非糖尿病患者 HbA1c 水平相关胰岛素抵抗的影响。
Am J Gastroenterol. 2010 Nov;105(11):2389-95. doi: 10.1038/ajg.2010.275. Epub 2010 Jul 13.
2
Standards of medical care in diabetes--2010.《糖尿病医疗护理标准——2010》
Diabetes Care. 2010 Jan;33 Suppl 1(Suppl 1):S11-61. doi: 10.2337/dc10-S011.
3
Causes and metabolic consequences of Fatty liver.脂肪肝的病因及代谢后果。
Long-chain saturated fatty acids and its interaction with insulin resistance and the risk of nonalcoholic fatty liver disease in type 2 diabetes in Chinese.
长链饱和脂肪酸及其与胰岛素抵抗及中国人 2 型糖尿病非酒精性脂肪肝发病风险的交互作用。
Front Endocrinol (Lausanne). 2022 Dec 7;13:1051807. doi: 10.3389/fendo.2022.1051807. eCollection 2022.
4
Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease.儿童非酒精性脂肪性肝病中高胰高血糖素血症的决定因素。
Front Endocrinol (Lausanne). 2022 Sep 5;13:1004128. doi: 10.3389/fendo.2022.1004128. eCollection 2022.
5
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease.KASL临床实践指南:非酒精性脂肪性肝病的管理
Clin Mol Hepatol. 2021 Jul;27(3):363-401. doi: 10.3350/cmh.2021.0178. Epub 2021 Jun 22.
6
The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease.肠道微生物群与非酒精性脂肪性肝病中膳食碳水化合物的相互作用。
Exp Mol Med. 2021 May;53(5):809-822. doi: 10.1038/s12276-021-00614-x. Epub 2021 May 20.
7
Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta-Analysis.瘦素正常的成年人非酒精性脂肪性肝病的患病率及概况:系统评价与荟萃分析
Hepatol Commun. 2020 May 21;4(7):953-972. doi: 10.1002/hep4.1519. eCollection 2020 Jul.
8
Fat and Sugar-A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease.脂肪和糖——危险的二重奏。非酒精性脂肪性肝病啮齿动物模型代谢重塑的比较综述。
Nutrients. 2019 Nov 24;11(12):2871. doi: 10.3390/nu11122871.
9
Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis.非酒精性脂肪性肝病(NAFLD)患者的实验室指标:非酒精性脂肪性肝病患者与无肝脂肪变性的肥胖患者的比较。
BMC Res Notes. 2018 Feb 6;11(1):101. doi: 10.1186/s13104-018-3212-1.
10
Non-alcoholic fatty liver disease and diabetes.非酒精性脂肪性肝病与糖尿病。
Metabolism. 2016 Aug;65(8):1096-108. doi: 10.1016/j.metabol.2016.01.001. Epub 2016 Jan 11.
Endocr Rev. 2008 Dec;29(7):939-60. doi: 10.1210/er.2008-0009. Epub 2008 Aug 21.
4
Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men.非酒精性脂肪性肝病是日本中年男性患2型糖尿病的一个风险因素。
Diabetes Care. 2007 Nov;30(11):2940-4. doi: 10.2337/dc07-0792. Epub 2007 Jul 31.
5
Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.非酒精性脂肪性肝病对代谢紊乱发生发展的影响。
J Gastroenterol Hepatol. 2007 Jul;22(7):1086-91. doi: 10.1111/j.1440-1746.2006.04781.x.
6
Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults.韩国成年人非酒精性脂肪性肝病的患病率及危险因素
J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):138-43. doi: 10.1111/j.1440-1746.2005.04086.x.
7
Non-alcoholic fatty liver disease: the unfolding monster?
J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):199-201. doi: 10.1111/j.1440-1746.2006.04206.x.
8
Fatty liver and the metabolic syndrome among Shanghai adults.上海成年人中的脂肪肝与代谢综合征
J Gastroenterol Hepatol. 2005 Dec;20(12):1825-32. doi: 10.1111/j.1440-1746.2005.04058.x.
9
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.代谢综合征作为非酒精性脂肪性肝病的预测指标。
Ann Intern Med. 2005 Nov 15;143(10):722-8. doi: 10.7326/0003-4819-143-10-200511150-00009.
10
[A study of the changes of hepatic gene expression in the process of nonalcoholic fatty liver disease development using U230A oligonucleotide microarray].[利用U230A寡核苷酸微阵列研究非酒精性脂肪性肝病发生过程中肝脏基因表达的变化]
Zhonghua Gan Zang Bing Za Zhi. 2005 Aug;13(8):597-601.